Westpac Banking Corp’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $586K | Sell |
2,003
-217
| -10% | -$71.3K | 0.04% | 256 |
|
|
2025
Q4 | $778K | Hold |
2,220
| – | – | 0.05% | 235 |
|
|
2025
Q3 | $717K | Hold |
2,220
| – | – | 0.04% | 238 |
|
|
2025
Q2 | $863K | Hold |
2,220
| – | – | 0.06% | 225 |
|
|
2025
Q1 | $966K | Sell |
2,220
-602
| -21% | -$242K | 0.07% | 223 |
|
|
2024
Q4 | $1.04M | Sell |
2,822
-121
| -4% | -$50.6K | 0.07% | 220 |
|
|
2024
Q3 | $1.53M | Buy |
2,943
+161
| +6% | +$86K | 0.1% | 192 |
|
|
2024
Q2 | $1.51M | Sell |
2,782
-445
| -14% | -$235K | 0.12% | 161 |
|
|
2024
Q1 | $1.67M | Sell |
3,227
-169
| -5% | -$84K | 0.13% | 165 |
|
|
2023
Q4 | $1.6M | Buy |
3,396
+532
| +19% | +$246K | 0.13% | 164 |
|
|
2023
Q3 | $1.25M | Sell |
2,864
-3,974
| -58% | -$1.8M | 0.09% | 199 |
|
|
2023
Q2 | $3.04M | Sell |
6,838
-61,437
| -90% | -$28.3M | 0.21% | 130 |
|
|
2023
Q1 | $31.4M | Sell |
68,275
-3,062
| -4% | -$1.46M | 0.42% | 39 |
|
|
2022
Q4 | $36.6M | Buy |
71,337
+23,878
| +50% | +$12.1M | 0.54% | 27 |
|
|
2022
Q3 | $21.6M | Sell |
47,459
-815
| -2% | -$390K | 0.33% | 67 |
|
|
2022
Q2 | $23.3M | Buy |
48,274
+6,950
| +17% | +$3.44M | 0.3% | 75 |
|
|
2022
Q1 | $20.3M | Sell |
41,324
-1,420
| -3% | -$649K | 0.23% | 106 |
|
|
2021
Q4 | $19.8M | Sell |
42,744
-4,689
| -10% | -$1.97M | 0.21% | 122 |
|
|
2021
Q3 | $17.7M | Buy |
47,433
+923
| +2% | +$351K | 0.19% | 139 |
|
|
2021
Q2 | $17.8M | Buy |
46,510
+14,131
| +44% | +$5.4M | 0.18% | 145 |
|
|
2021
Q1 | $11.6M | Sell |
32,379
-477
| -1% | -$153K | 0.13% | 208 |
|
|
2020
Q4 | $10.5M | Sell |
32,856
-6,002
| -15% | -$1.84M | 0.12% | 224 |
|
|
2020
Q3 | $10.4M | Sell |
38,858
-5,802
| -13% | -$1.56M | 0.14% | 180 |
|
|
2020
Q2 | $11.7M | Sell |
44,660
-5,452
| -11% | -$1.45M | 0.18% | 148 |
|
|
2020
Q1 | $11.4M | Buy |
50,112
+13,604
| +37% | +$3.71M | 0.2% | 142 |
|
|
2019
Q4 | $11M | Buy |
36,508
+2,554
| +8% | +$703K | 0.14% | 194 |
|
|
2019
Q3 | $8.15M | Sell |
33,954
-5,173
| -13% | -$1.42M | 0.11% | 251 |
|
|
2019
Q2 | $11M | Sell |
39,127
-7,506
| -16% | -$2.05M | 0.17% | 162 |
|
|
2019
Q1 | $13.4M | Buy |
46,633
+14,086
| +43% | +$4.07M | 0.22% | 127 |
|
|
2018
Q4 | $8.55M | Buy |
32,547
+1,572
| +5% | +$432K | 0.15% | 188 |
|
|
2018
Q3 | $8.49M | Buy |
30,975
+9,492
| +44% | +$2.46M | 0.15% | 199 |
|
|
2018
Q2 | $5.11M | Hold |
21,483
| – | – | 0.1% | 288 |
|
|
2018
Q1 | $4.72M | Buy |
21,483
+3,559
| +20% | +$836K | 0.09% | 283 |
|
|
2017
Q4 | $4.03M | Hold |
17,924
| – | – | 0.09% | 295 |
|
|
2017
Q3 | $3.4M | Sell |
17,924
-404
| -2% | -$76.9K | 0.07% | 329 |
|
|
2017
Q2 | $3.45M | Sell |
18,328
-50,893
| -74% | -$9.14M | 0.08% | 322 |
|
|
2017
Q1 | $11.4M | Buy |
69,221
+14,679
| +27% | +$2.34M | 0.09% | 226 |
|
|
2016
Q4 | $10.1M | Sell |
54,542
-26,885
| -33% | -$3.6M | 0.1% | 231 |
|
|
2016
Q3 | $10.2M | Sell |
81,427
-71,868
| -47% | -$9.28M | 0.11% | 187 |
|
|
2016
Q2 | $17.9M | Sell |
153,295
-22,019
| -13% | -$3.01M | 0.2% | 126 |
|
|
2016
Q1 | $24.4M | Buy |
175,314
+7,072
| +4% | +$945K | 0.26% | 87 |
|
|
2015
Q4 | $23.5M | Sell |
168,242
-9,736
| -5% | -$1.34M | 0.26% | 101 |
|
|
2015
Q3 | $24.9M | Sell |
177,978
-7,489
| -4% | -$1.13M | 0.27% | 84 |
|
|
2015
Q2 | $30.4M | Buy |
185,467
+4,515
| +2% | +$721K | 0.3% | 64 |
|
|
2015
Q1 | $32.6M | Sell |
180,952
-1,394
| -0.8% | -$198K | 0.28% | 74 |
|
|
2014
Q4 | $22.9M | Sell |
182,346
-1,252
| -0.7% | -$155K | 0.22% | 108 |
|
|
2014
Q3 | $22M | Sell |
183,598
-2,620
| -1% | -$301K | 0.21% | 105 |
|
|
2014
Q2 | $20M | Sell |
186,218
-2,670
| -1% | -$275K | 0.19% | 126 |
|
|
2014
Q1 | $18.8M | Buy |
188,888
+16,291
| +9% | +$1.47M | 0.2% | 121 |
|
|
2013
Q4 | $15.9M | Buy |
172,597
+28,100
| +19% | +$2.5M | 0.18% | 145 |
|
|
2013
Q3 | $12.1M | Buy |
144,497
+101,738
| +238% | +$8.72M | 0.15% | 162 |
|
|
2013
Q2 | $3.05M | Buy |
+42,759
| New | +$3.2M | 0.05% | 350 |
|
Other funds holding ELV
VCM
VPM
Westpac Banking Corp's ELV Position: Q1 2026 in Review
Westpac Banking Corp reduced its Elevance Health (ELV) stake by 9.8% in Q1 2026, selling an estimated $71.3K and leaving 2,003 shares worth $586K. The position accounts for 0.04% of the portfolio, ranked #256.
Westpac Banking Corp first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Westpac Banking Corp held 2,003 shares of Elevance Health worth $586K as of Q1 2026.
- Westpac Banking Corp sold 217 Elevance Health shares in Q1 2026, an estimated $71.3K.
- Elevance Health made up 0.04% of Westpac Banking Corp's portfolio in Q1 2026, its #256 holding.
- Westpac Banking Corp first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Westpac Banking Corp's Elevance Health position peaked at $36.6M in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.